期刊文献+

中国肾脏移植受者非泌尿系统肿瘤诊疗指南(2023版)

Chinese guidelines for clinical diagnosis and treatment of non-urinary tract tumors in kidney transplant recipients(2023 edition)
原文传递
导出
摘要 目前,肾脏移植术后并发肿瘤已是大多数国家肾脏移植受者的第2大死亡原因,直接关系受者的长期存活及生存质量,需要临床高度关注。肾脏移植术后并发肿瘤的发生风险是与之年龄和性别匹配的普通人群的2~3倍,主要是由病毒和免疫相关因素导致。一旦肿瘤进展,通常预后很差,特别是黑色素瘤、肾细胞癌和移植后淋巴增生性疾病。为进一步规范肾脏移植术后非泌尿系统肿瘤的诊断与治疗,中华医学会器官移植学分会发起制订《中国肾脏移植受者非泌尿系统肿瘤诊疗指南(2023版)》,并组织器官移植学专家,依据现有临床指南、系统评价、病例研究、专家共识等资料,总结近年来国内外在肾脏移植受者术后非泌尿系统肿瘤诊治方面的新进展,以期为肾脏移植术后非泌尿系统肿瘤的诊疗提供参考。 Post-transplant malignancies have become the second leading cause of mortality among kidney transplant(KT)recipients in many countries,significantly affecting long-term survival and quality-of-life.This issue demands heightened clinical awareness.The risk of developing tumors after KT is approximately two to three folds higher than that of general population matched by age and gender,primarily due to viral and immune-related factors.Once tumors progress,the prognosis is often poor,particularly in cases of melanoma,kidney cell carcinoma and post-transplant lymphoproliferative disorders.To further standardize the managements of non-urinary tract tumors after KT,Branch of Organ Transplantation,Chinese Medical Association initiated the drafting of the Chinese guideline for clinical diagnosis and treatment of non-urinary tract tumors in kidney transplant recipients(2023 edition).Compiled by senior experts in organ transplantation,this guideline was based upon existing clinical guidelines,systematic reviews,case studies and expert consensus.It summarized the latest advances in the diagnosis and treatment of non-urinary tract tumors in KT recipients,both domestically and internationally,with an objective goal of providing valuable references for managing non-urinary tract tumors in KT recipients.
作者 中华医学会器官移植学分会 田野 Branch of Organ Transplantation,Chinese Medical Association;Tian Ye(不详;Department of Urology,Beijing Friendship Hospital,Capital Medical University,Institute of Urology,Beijing Municipal Health Commission,Beijing 100050,china)
出处 《中华器官移植杂志》 CAS 2024年第10期689-698,共10页 Chinese Journal of Organ Transplantation
基金 国家自然科学基金(82000717) 北京市自然科学基金(7192043、7194250) 北京市医院管理中心"青苗计划"计划项目(QML20190106) 北京市医师科学家培训项目(BJPSTP-2024-30)。
关键词 肾脏移植 肿瘤 诊断 治疗 指南 Kidney transplantation Tumors Diagnosis Treatment Guideline
  • 相关文献

参考文献4

二级参考文献34

  • 1蒋婉洁,卢一平.KDIGO临床实践指南:肾移植受者的诊治[J].中华移植杂志(电子版),2010,4(2):156-164. 被引量:26
  • 2顾坚未,王祥慧,徐达,周佩军,施国海,尧凯.新型免疫抑制剂SRL在器官移植受者中的转换治疗评价[J].上海交通大学学报(医学版),2006,26(6):675-679. 被引量:3
  • 3林俊,田野,唐雅望,杜林栋,郭宏波,解泽林,孙雯,张磊.肾移植后泌尿系统肿瘤患者应用西罗莫司替代钙调磷酸酶抑制剂九例[J].中华器官移植杂志,2007,28(4):205-207. 被引量:5
  • 4Saidi RF, Dudrick PS, Goldman MH. Colorectal cancer after renal transplantation. Transplant Proc 2003; 35:1410-1412.
  • 5Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4:905-913.
  • 6Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE. Cancer incidence before and after kidney transplantation. Jama 2006; 296:2823-2831.
  • 7Sheil AGR. In: Morris PJ editor. Kidney Transplantation: Principles and Practice. 5th ed. Philadelphia: Saunders, 2001:558.
  • 8Anaya F, Plaza J, Sanz-Guajardo D, Luque A, Rengel M, Fernandez J, Moreno M. Cancer after renal transplantation. Transplant Proc 2003; 35:697-699.
  • 9Buell JF, Gross TG, Woodle ES. Malignancy after transplan- tation. Transplantation 2005; 80:$254-$264.
  • 10Ho HT, Russ G, Stephens J, Rieger N. Colorectal cancer in patients with chronic renal failure: the effect of dialysis or renal transplantation. Colorectal Dis 2002; 4:193-196.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部